Equities

Alliance Pharma PLC

Alliance Pharma PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)33.78
  • Today's Change-0.22 / -0.65%
  • Shares traded135.03k
  • 1 Year change-49.28%
  • Beta0.8383
Data delayed at least 20 minutes, as of May 02 2024 09:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade Alliance Pharma PLC (APH:LSE) traded at 33.78, 0.61% above its 52-week low of 33.57, set on Apr 30, 2024.
52-week range
Today
33.57Apr 30 202473.04May 17 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open34.30
High34.30
Low33.75
Bid33.75
Offer34.00
Previous close34.00
Average volume1.85m
Shares outstanding540.40m
Free float476.86m
P/E (TTM)--
Market cap183.74m GBP
EPS (TTM)-0.0131
GBP
Annual div (ADY)--
Annual div yield (ADY)--
Div ex-dateJun 22 2023
Div pay-dateJul 18 2023
Data delayed at least 20 minutes, as of May 02 2024 09:05 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Alliance Pharma PLC shares was Hold at 51.00 on 26 Sep 2023Read the full article
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.